Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein (Q24457210)

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Heparan sulfate and viral tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

From the World Health Organization. Development of dengue and Japanese encephalitis vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Serological evidence of West Nile virus, Usutu virus and Sindbis virus infection of birds in the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Generation and characterization of organ-tropism mutants of Japanese encephalitis virus in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Mutations in the NS3 gene and 3'-NCR of Japanese encephalitis virus isolated from an unconventional ecosystem and implications for natural attenuation of the virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Phenotypic changes in the Japanese encephalitis virus after one passage in Neuro-2a cells: generation of attenuated strains of the virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Fitness of Japanese encephalitis virus to Neuro-2a cells is determined by interactions of the viral envelope protein with highly sulfated glycosaminoglycans on the cell surface.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Characterization of plasma membrane-associated proteins from Aedes albopictus mosquito (C6/36) cells that mediate West Nile virus binding and infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Cholesterol metabolism in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Lactoferrin inhibits human papillomavirus binding and uptake in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

The binding of lactoferrin to glycosaminoglycans on enterocyte-like HT29-18-C1 cells is mediated through basic residues located in the N-terminus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Study of Japanese encephalitis virus in Chiangmai Valley, Thailand. 3. Human seroepidemiology and inapparent infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

The survival of ingested lactoferrin in the gastrointestinal tract of adult mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Japanese encephalitis virus is transported across the cerebral blood vessels by endocytosis in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Differential binding efficiency between the envelope protein of Japanese encephalitis virus variants and heparan sulfate on the cell surface.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Lactoferrin, an iron-binding protein in neutrophilic leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

The anti-papillomavirus activity of human and bovine lactoferricin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Simultaneous infection with dengue 1 and 2 in a Brazilian patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Highly sulfated forms of heparin sulfate are involved in japanese encephalitis virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

A novel bovine lactoferrin peptide, FKCRRWQWRM, suppresses Candida cell growth and activates neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Antiviral activity of human lactoferrin: inhibition of alphavirus interaction with heparan sulfate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Human lactoferrin: a novel therapeutic with broad spectrum potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Bovine lactoferrin and Lactoferricin inhibit tumor metastasis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Studies of Japanese Encephalitis in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

Binding of Sindbis virus to cell surface heparan sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017

inferred from DOI database lookup

7 January 2021

based on heuristic

A single amino acid change in the E2 glycoprotein of Sindbis virus confers neurovirulence by altering an early step of virus replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.017